English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/214145
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage

AuthorsGalindo-Moreno, María; Giráldez, Servando; Limón-Mortés, M. C.; Belmonte-Fernández, Alejandro; Reed, Steven I.; Sáez, Carmen; Japón, Miguel A. ; Tortolero, María; Romero, Francisco
KeywordsUbiquitylation
Proliferation
Cancer
FBXW7 inhibitors
Issue DateOct-2019
PublisherFederation of American Society of Experimental Biology
CitationFASEB Journal 33(10): 11420-11430 (2019)
AbstractEukaryotic cells have developed sophisticated mechanisms to ensure the integrity of the genome and prevent the transmission of altered genetic information to daughter cells. If this control system fails, accumulation of mutations would increase risk of diseases such as cancer. Ubiquitylation, an essential process for protein degradation and signal transduction, is critical for ensuring genome integrity as well as almost all cellular functions. Here, we investigated the role of the SKP1–Cullin‐1–F‐box protein (SCF)‐[F‐box and tryptophan‐aspartic acid (WD) repeat domain containing 7 (FBXW7)] ubiquitin ligase in cell proliferation by searching for targets implicated in this process. We identified a hitherto‐unknown FBXW7‐interacting protein, p53, which is phosphorylated by glycogen synthase kinase 3 at serine 33 and then ubiquitylated by SCF(FBXW7) and degraded. This ubiquitylation is carried out in normally growing cells but primarily after DNA damage. Specifically, we found that SCF(FBXW7)‐specific targeting of p53 is crucial for the recovery of cell proliferation after UV‐induced DNA damage. Furthermore, we observed that amplification of FBXW7 in wild‐type p53 tumors reduced the survival of patients with breast cancer. These results provide a rationale for using SCF(FBXW7) inhibitors in the treatment of this subset of tumors.—Galindo‐Moreno, M., Giráldez, S., Limón‐Mortés, M. C., Belmonte‐Fernández, A., Reed, S. I., Sáez, C., Japón, M. Á., Tortolero, M., Romero, F. SCF(FBXW7)‐mediated degradation of p53 promotes cell recovery after UV‐induced DNA damage.
Publisher version (URL)http://dx.doi.org/10.1096/fj.201900885R
URIhttp://hdl.handle.net/10261/214145
DOIhttp://dx.doi.org/10.1096/fj.201900885R
ISSN0892-6638
E-ISSN1530-6860
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.